13 results
424B3
BLRX
Bioline Rx Ltd
8 Aug 13
Prospectus supplement
12:00am
received a single dose of either 16mg, 24mg or 32mg of BL-1020. We assessed receptor occupancy using positron emission tomography (PET scan), which
6-K
EX-10.1
BLRX
Bioline Rx Ltd
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
, activities, circumstances, conditions, events, or incidents, including, without limitation, the release, emission, discharge, presence, or disposal of any
424B3
BLRX
Bioline Rx Ltd
15 Oct 12
Prospectus supplement
12:00am
using positron emission tomography, or a PET scan, that is able to register the activity of various parts of the brain following the administration
F-1
BLRX
Bioline Rx Ltd
2 Oct 12
Registration statement (foreign)
12:00am
a single dose of either 10mg, 15mg or 20mg of BL-1020. We assessed receptor occupancy using positron emission tomography, or a PET scan, that is able
424B3
3tbdu1
28 Mar 12
Prospectus supplement
12:00am
20-F
ekls0h67avyaebycn4f
22 Mar 12
Annual report (foreign)
12:00am
6-K
EX-99.2
n0o8 ysilf2379
16 Feb 12
Current Report, Foreign Issuer
12:00am
20FR12B/A
ufdhtav5gk0lnq8z10q6
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
8u48skycw1l na
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.19
ymphbct 9kxzg6
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
F-1
EX-10.19
dps8u2x
24 Sep 10
Registration statement (foreign)
12:00am
F-1
zgbqbffw0rudt8asmw1
24 Sep 10
Registration statement (foreign)
12:00am
- Prev
- 1
- Next